(For more market insights, including options activity, click on
; for the Day Ahead newsletter link.reuters.com/mex49s;
for the Morning News Call newsletter, link.reuters.com/nex49s)
Sept 12 Some U.S. stocks to watch on Thursday:
FUTURES FLAT BEFORE WEEKLY JOBLESS CLAIMS REPORT
U.S. stock index futures were little changed after a
seven-days straight rise by stocks and before a jobless claims
report which could influence investors' bets about the Federal
Reserve's stimulus policy. S&P 500 futures fell 0.3
points, Dow Jones industrial average futures shed 1
points, and Nasdaq 100 futures added 3 points.
** FACEBOOK INC, Wednesday close $45.04, up 1 pct
Shares of Facebook rose more than 3 percent to a new high on
Wednesday, valuing the world's No. 1 social network at $106
billion, as investors focused on its recent mobile advertising
advances and the potential to expand ad revenue into new areas.
** VERTEX PHARMACEUTICALS INC, Wednesday close
$79.81, up 3 pct premarket
** AMETEK INC, Wednesday close $44.43, up 2 pct
** ADVANCED MICRO DEVICES INC, Wednesday close
$3.82, down 2 pct premarket
** SAIC Inc, Wednesday close $14.77
S&P Dow Jones Indices announced late Wednesday that Vertex
Pharmaceuticals and Ametek will replace Advanced Micro Devices
and SAIC in the S&P 500 after the close of trading on Sept. 20.
** NETSOL TECHNOLOGIES, Wednesday close $10.20, up
17 pct premarket
The company, which provides software and IT services for
financial, automotive leasing and healthcare industries, posted
fourth-quarter results way ahead of Wall Street estimates as
demand rose for its services. The company said its average deal
size is increasing.
** LULULEMON ATHLETICA INC, $69.02, down 9 pct
The retailer , recovering from a setback after its
see-through yoga pants were recalled earlier this year, trimmed
its forecast. For the 2013 full fiscal year, the company expects
net revenue in the range of $1.625 billion to $1.635 billion,
down from $1.645 billion to $1.665 billion previously
** VERA BRADLEY INC, Wednesday close $19.45, down 11
The women's handbag and accessories retailer forecast
third-quarter results below Wall Street estimates as it expects
its gross margin to decline due to increased promotional
activity. The company also lowered its full-year profit and
** MEN'S WEARHOUSE INC, Wednesday close $38.77, down
14 pct premarket
The retailer reported lower-than-expected results for the
second quarter and lowered its full-year earnings forecast,
citing difficult macro trends in the apparel industry.
** SANOFI SA, Wednesday close $49.21, down 2 pct
The French drugmaker said it would withdraw its U.S.
application for diabetes treatment lixisenatide to wait for
results from an ongoing cardiovascular patient study. The
decision will delay the drug's launch in the world's biggest
** EXTREME NETWORKS INC, Wednesday close $4.03, up
10 pct premarket
The network-gear maker said it would buy privately held
wired and wireless network hardware and software company
Enterasys Networks Inc for $180 million in cash. Extreme
Networks expects the deal to add to earnings immediately.
** SYNTA PHARMACEUTICALS CORP, Wednesday close
$6.74, up 11 pct premarket
The company said the U.S. Food and Drug Administration
granted fast-track status to its lead experimental drug
ganetespib as a treatment for non-small cell lung cancer.
A fast-track designation expedites regulatory
review of drugs that aim to treat serious diseases and fill
unmet medical needs.
** DOMINION RESOURCES INC Wednesday close $58.61, up 5
The Obama administration on Wednesday authorized natural gas
exports from a fourth U.S. facility -- Dominion Resource's Cove
Point terminal on Maryland's Chesapeake Bay -- unexpectedly
accelerating a review process that would-be gas exporters and
their allies in Congress had criticized as too slow.
** WEATHERFORD INTERNATIONAL LTD, Wednesday close
$15.74, down 8 pct premarket
Brokerage Raymond James downgraded the oilfield services
company's stock to "market perform" from "outperform", citing
its "overly optimistic" full-year forecast and the management
uncertainty following the departure of Chief Financial Officer
** ROYAL CARIBBEAN CRUISES LTD, Wednesday close
$38.72, up 4 pct premarket
The world's second-biggest cruise operator more than doubled
its dividend to 25 cents per share for the third quarter from 12
cents per share in the preceding quarter.
** ARCH COAL INC, Wednesday close $5.11
** ALPHA NATURAL RESOURCES INC, Wednesday close
** JAMES RIVER COAL CO, Wednesday close $2.30
** PEABODY ENERGY CORP, Wednesday close $18.69
** WALTER ENERGY INC, Wednesday close $15.32
The Obama administration plans to block the construction of
new coal-fired power plants unless they are built with novel and
expensive technology to capture greenhouse gases, the Wall
Street Journal reported. (link.reuters.com/kyr92v)
China unveiled comprehensive new measures to tackle air
pollution, with plans to slash coal consumption and close
polluting mills, factories and smelters, but experts said
implementing the bold targets would be a major challenge.
** CLIFF NATURAL RESOURCES, Wednesday close $23.64,
down 1.6 pct premarket
Miner Cliffs Natural Resources Inc CLF.N has lost a key land
dispute at a Canadian tribunal that could cause more problems
for its already troubled Black Thor chromite project in northern
Ontario's mineral-rich Ring of Fire.
** HALCON RESOURCES CORP, Wednesday close $4.93, up
2.4 pct premarket
The oil and gas company said it would sell some non-core
assets in the United States for about $302 million. The company
said the assets produce about 4,500 barrels of oil equivalent
** GLU MOBILE INC, Wednesday close $2.41, down 6.6
pct after market
The mobile game maker reaffirmed its forecast for the third
quarter, which were largely below analysts' expectations. The
company had forecast an adjusted loss of 10 cents to 11 cents on
revenue of $19.6 million to $21 million. Analysts were expecting
a loss of 10 cents on revenue of $20.3 million.
** ZYNGA INC, Wednesday close $3.00, up 2 pct
Brokerage Evercore Partners upgraded the game publisher's
stock to "equal weight" from "underweight" as it expects Zynga
to launch a game to compete with King's "Candy Crush Saga".
** REYNOLDS AMERICAN INC, Wednesday close $48.21
** LORILLARD INC, Wednesday close $44.08
** ALTRIA GROUP INC, Wednesday close $35.41
U.S. cigarette makers lost a bid to reduce payments to nine
states that were part of a landmark 1998 tobacco settlement, an
arbitration panel ruled on Wednesday.
** JINKO SOLAR HOLDING CO LTD, Wednesday close
The solar panel maker said it was aiming to expand its
grid-linked projects to 200 megwatt (MW) by the end of the year.
The company expects to ramp that up to 500 MW by the end of
2014, generating about 590 million yuan ($96.43 million) in
** PANDORA MEDIA INC, Wednesday close $21.38, up 5 pct
The online streaming music company named former Microsoft
Corp executive and venture capitalist Brian McAndrews
as president, chairman and CEO on Wednesday. McAndrews, 54,
replaces Joe Kennedy who announced in March he was leaving
** JPMORGAN CHASE & CO, Wednesday close $53.26
The biggest U.S.-based bank may settle probes by U.S.
regulators into its credit card debt collection practices and
sales of identity-theft products within weeks, according to a
person familiar with the matter. JPMorgan had previously
disclosed the credit card and identity-theft product
investigations. Reuters' source, who declined to be identified
by name, said talks about a settlement have been on and off for
months but have heated up recently.
** TIME WARNER CABLE INC, Wednesday close $110.43
A company executive said the pay TV operator lost
subscribers during a month-long blackout of CBS Corp in
three major markets, while the broadcast network's CEO said it
suffered no financial harm from rate dispute.
** JOHNSON & JOHNSON, Wednesday close $89.23
The company is voluntarily recalling one lot of
schizophrenia drug Risperdal Consta after discovering mold
during a routine testing process, a company spokeswoman said,
the latest in a string of recalls over the past two years.
** BRISTOL-MYERS SQUIBB CO, Wednesday close $43.26
The drugmaker's immunotherapy drug Yervoy failed to
significantly prolong survival among patients with advanced
prostate cancer who had previously received chemotherapy,
according to limited data from the first late-stage study of the
drug for the condition.
(Compiled by Varun Aggarwal; Editing by Don Sebastian)